![](/img/cover-not-exists.png)
Dose-Dependent Treatment Benefit in High-Risk Melanoma Patients Receiving Adjuvant High-Dose Interferon Alfa-2b
Fluck, Michael, Kamanabrou, Darab, Lippold, Andrea, Reitz, Martina, Atzpodien, JensVolume:
20
Language:
english
Journal:
Cancer Biotherapy & Radiopharmaceuticals
DOI:
10.1089/cbr.2005.20.280
Date:
June, 2005
File:
PDF, 114 KB
english, 2005